Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-11-21
pubmed:abstractText
Various inflammatory diseases are characterized by tissue infiltration of neutrophils. Chemokines recruit and activate leukocytes, but neutrophils are traditionally known to be restricted in their chemokine receptor (CR) expression repertoire. Neutrophils undergo phenotypic and functional changes under inflammatory conditions, but the mechanisms regulating CR expression of infiltrated neutrophils at sites of chronic inflammation are poorly defined. Here we show that infiltrated neutrophils from patients with chronic inflammatory lung diseases and rheumatoid arthritis highly express CR on their surface that are absent or only marginally expressed on circulating neutrophils, i.e., CCR1, CCR2, CCR3, CCR5, CXCR3, and CXCR4, as measured by flow cytometry, immunohistochemistry, and confocal microscopy. The induction of CR surface expression on infiltrated neutrophils was functionally relevant, because receptor activation by chemokine ligands ex vivo modulated neutrophil effector functions such as respiratory burst activity and bacterial killing. In vitro studies with isolated neutrophils demonstrated that the surface expression of CR was differentially induced in a cytokine-mediated, protein synthesis-dependent manner (CCR1, CCR3), through Toll-like (CXCR3) or NOD2 (CCR5) receptor engagement, through neutrophil apoptosis (CCR5, CXCR4), and/or via mobilization of intracellular CD63(+) granules (CXCR3). CR activation on infiltrated neutrophils may represent a key mechanism by which the local inflammatory microenvironment fine-tunes neutrophil effector functions in situ. Since the up-regulation of CR was exclusively found on infiltrated neutrophils at inflammatory sites in situ, the targeting of these G protein-coupled receptors may have the potential to site-specifically target neutrophilic inflammation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1550-6606
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
181
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8053-67
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19017998-Adult, pubmed-meshheading:19017998-Aged, pubmed-meshheading:19017998-Antigens, CD, pubmed-meshheading:19017998-Antigens, CD63, pubmed-meshheading:19017998-Arthritis, Rheumatoid, pubmed-meshheading:19017998-Chronic Disease, pubmed-meshheading:19017998-Female, pubmed-meshheading:19017998-Flow Cytometry, pubmed-meshheading:19017998-Gene Expression Regulation, pubmed-meshheading:19017998-Humans, pubmed-meshheading:19017998-Immunochemistry, pubmed-meshheading:19017998-Inflammation, pubmed-meshheading:19017998-Male, pubmed-meshheading:19017998-Middle Aged, pubmed-meshheading:19017998-Neutrophil Infiltration, pubmed-meshheading:19017998-Neutrophils, pubmed-meshheading:19017998-Platelet Membrane Glycoproteins, pubmed-meshheading:19017998-Pneumonia, pubmed-meshheading:19017998-Receptors, Chemokine, pubmed-meshheading:19017998-Secretory Vesicles
pubmed:year
2008
pubmed:articleTitle
Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases.
pubmed:affiliation
Childrens' Hospital, Ludwig-Maximilians-University, Munich, Germany. dhartl@med.uni-muenchen.de
pubmed:publicationType
Journal Article